Golden Meditech Holdings Limited, an investment holding company, operates as an integrated healthcare company in the People’s Republic of China. It operates in five segments: Medical Devices, Hospital Business, Medical Insurance Administration, Chinese Herbal Medicines, and Cells and Tissues Storage and Genetic Testing Services. The Medical Devices segment develops, manufactures, and sells medical devices and accessories that are specialized in blood recovery, purification, and treatment. The Hospital Business segment offers hospital management services; and operates three hospitals in Beijing and Shanghai that provide obstetrics, gynecology, and pediatric medical services, as well as haematology treatments and other healthcare services. The Medical Insurance Administration segment offers medical insurance administration services. This segment provides operational and information technology solutions to insurance companies and healthcare institutions, as well as offers bill settlement, and review management and services to governmental healthcare insurance agencies. The Chinese Herbal Medicine segment engages in the research and development, manufacture, and sale of Chinese herbal medicines. The Cells and Tissues Storage and Genetic Testing Services segment engages in the collection, processing, storage, and clinical application of cells and tissues, as well as provision of clinical molecular genetic testing and molecular pathology testing services. The company also engages in the software design business. Golden Meditech Holdings Limited has a collaboration with the Department of Biology of Hong Kong Baptist University to conduct research in the area of cell therapy. The company was formerly known as Golden Meditech Company Limited and changed its name to Golden Meditech Holdings Limited in March 2010. Golden Meditech Holdings Limited was incorporated in 2001 and is headquartered in Beijing, the People’s Republic of China.